Publications by authors named "Natalia Castano Gamboa"
Background: Breast Cancer (BC) is associated with substantial costs of healthcare; however, real-world data regarding these costs in Colombia is scarce. The contributory regime provides healthcare services to formal workers and their dependents and covers almost half of the population in Colombia. This study aims to describe the net costs of healthcare in women with BC covered by the contributory regime in Colombia in 2019 from the perspective of the Colombian Health System.
View Article and Find Full Text PDFThe frequency of complications in a cohort of patients diagnosed with hemophilia A and hemophilia B receiving prophylactic treatment in Colombia: A retrospective noninterventional study.
PLoS One
November 2023
Introduction: Hemophilia A and B are disorders associated with the deficit of coagulation factors VIII and IX.
Objective: Was to determine the incidence of complications in a cohort of patients diagnosed with moderate and severe hemophilia A or B under treatment in a specialized institution.
Methods: A retrospective study of a cohort of patients with replacement therapy for hemophilia A or B, evaluating treatment and complications between January/2012 and July/2019.
Clinical Characteristics, Patterns of Use, and incidence of Adverse Events in Patients With Nonvalvular Atrial Fibrillation Treated With Oral Anticoagulants in Colombia.
Vasc Health Risk Manag
April 2023
Article Synopsis
- The study focused on Colombian patients with non-valvular atrial fibrillation (NVAF) using oral anticoagulants, analyzing their characteristics and treatment outcomes.
- A total of 2076 patients were examined, revealing that the majority were older women with common conditions like hypertension and diabetes, with rivaroxaban being the most prescribed OA.
- While thrombotic event rates were similar between warfarin and direct oral anticoagulants, warfarin users experienced significantly more bleeding complications and had lower treatment persistence.
Objectives: To assess budget impact of the implementation of an anticoagulation clinic (AC) compared to usual care (UC), in patients with non-valvular atrial fibrillation (NVAF).
Method: A decision tree was designed to analyze the cost and events rates over a 1-year horizon. The patients were distributed according to treatment, 30% Direct Oral Anticoagulant (DOAC) regimens and the rest to warfarin.
Introduction/objectives: The objective of this study is to describe the treatment patterns and use of healthcare resources in a cohort of Colombian patients with rheumatoid arthritis (RA) treated with biological disease-modifying antirheumatic drugs (bDMARDs) or tofacitinib.
Method: This is a descriptive study from a retrospective cohort of patients diagnosed with RA who were treated with bDMARDs or tofacitinib after failure of conventional DMARDs (cDMARDs) or first bDMARD. Patients who were receiving pharmacological treatment between 01 January 2014 and 30 June 2018 were included.